TrialEuropean journal of drug metabolism and pharmacokinetics2023

First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MHV370, a Dual Inhibitor of Toll-Like Receptors 7 and 8, in Healthy Adults.

Tamas Shisha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.